Sumitomo Dainippon Pharma Co Ltd's Fiscal Year is From April To March.
The item "Fixed-Asset-Turnover" stands at 8.21 as of 06/30/2025, the highest value since 06/30/2023.
As of the end of Sumitomo Dainippon Pharma Co Ltd's first quarter, the item "Fixed Asset Turnover" stands at 8.21. This represents an increase of 11.32 percent compared to it's value at the end of it's fourth quarter of the company's last fiscal year.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 47.48 percent compared to the value the year prior.
The 1 year change in percent is 47.48.
The 3 year change in percent is -11.55.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Fixed Asset Turnover | 905,699,262,464.00 |
![]() | Johnson & Johnson - Fixed Asset Turnover | 486,508,953,600.00 |
![]() | AbbVie Inc - Fixed Asset Turnover | 399,570,305,024.00 |
![]() | Roche Holding AG - Fixed Asset Turnover | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Fixed Asset Turnover | 280,205,508,085.11 |